5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), an enzyme that methylates nicotinamide and depletes SAM and NAD+ in cells. By blocking NNMT, 5-Amino-1MQ increases intracellular NAD+ levels in adipocytes, boosting sirtuin activity and mitochondrial energy metabolism. This shift promotes fat cell shrinkage and enhances energy expenditure without affecting appetite signaling pathways.
5-Amino-1MQ — NNMT Inhibitor for Metabolic Research
A small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied in metabolic research for its potential effects on cellular energy metabolism and fat cell regulation.
CAS 42464-85-3 • 214.26 g/mol • Oral (research use) • Per research workflow
5-Amino-1MQ Structure
Reference identifiers are batch-specific for coded materials and are documented on the lot COA/SDS rather than inferred or estimated.
Mechanism of Action
5-Amino-1MQ Overview
5-Amino-1MQ is a cell-permeable small molecule that selectively inhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in adipose tissue and linked to metabolic research and metabolic dysfunction. NNMT degrades SAM (S-adenosyl methionine) and reduces intracellular NAD+ levels, both of which play critical roles in energy homeostasis. By blocking NNMT activity, 5-Amino-1MQ may help restore NAD+ concentrations in adipocytes and promote healthier cellular energy metabolism. Preclinical research has shown that NNMT inhibition with 5-Amino-1MQ can reduce fat mass in diet-induced metabolic research models without affecting food intake. The compound appears to work by shrinking fat cells rather than reducing their number, increasing energy expenditure at the cellular level. Studies have also observed improvements in key metabolic markers, including cholesterol profiles and overall body composition in animal models. 5-Amino-1MQ has attracted attention as a novel research tool for studying metabolic pathways because it targets a mechanism distinct from traditional approaches. Unlike compounds that act on appetite or absorption, NNMT inhibition addresses energy metabolism directly within adipose tissue. PharmaOrder supplies 5-Amino-1MQ as non-public oral-format references for research applications, with independent third-party testing available through Finnrick Analytical. For research use only. Not intended for human consumption.
Purity & Testing
5-Amino-1MQ is listed as 50mg capsules x 30; 50mg capsules x 60. Catalog identity: CAS 42464-85-3; formula C13H14N2O; molecular weight 214.26 g/mol. The lot COA for 5-Amino-1MQ is available in your account. Finnrick Analytical performs HPLC purity analysis and mass spectrometry identity confirmation on that lot.
- Catalog configurations: 50mg capsules x 30, 50mg capsules x 60
- CAS: 42464-85-3
- Formula: C13H14N2O
- Molecular weight: 214.26 g/mol
See the 5-Amino-1MQ COA page.
Storage & Handling
Store at room temperature in a cool, dry place. Protect from moisture and light.
Shipping
Ships worldwide from 6 distribution centers via USPS Ground Advantage
Available for direct research purchase
Research-use-only products are sold strictly for laboratory and research purposes. By purchasing, you acknowledge that these products are not intended for human or veterinary use, and you agree to PharmaOrder's RUO terms of service.
Published Research
Selected peer-reviewed studies referenced in this product overview.
FAQ
What is 5-Amino-1MQ?
What is NNMT and why is it relevant to metabolic research?
How should 5-Amino-1MQ capsules be stored?
How does 5-Amino-1MQ differ from other metabolic research compounds?
Compare 5-Amino-1MQ
Related Products
AOD-9604
A synthetic peptide fragment of human growth hormone (amino acids 177-191) studied for lipid-metabolism (lipolysis) pathways in vitro.
MOTS-c
A 16-amino-acid peptide encoded in mitochondrial DNA, studied for its role in metabolic homeostasis, exercise-induced stress response, and insulin sensitivity.
Ready to order 5-Amino-1MQ?
In stock. Ships within 24 hours, with tracking.
Order Now